Aneurysm Biology, Screening, Surveillance, and Decision Frameworks

18.1How this chapter answers the AAA questions you are likely to face

Abdominal aortic aneurysm care is easiest to teach as an ordered pathway rather than as a collection of isolated thresholds. The initial step is determining whether an asymptomatic adult has enough prior probability to justify one-time abdominal ultrasound screening; the next is whether the measured infrarenal diameter is normal, subaneurysmal, a small aneurysm for surveillance, or large enough to prompt repair discussion. Once an aneurysm is present, every subsequent visit should answer three questions: has the diameter changed enough to alter the imaging interval, has morphology or symptom status changed the repair threshold, and is the patient fit enough that elective repair would be safer than continued observation?

That sequence explains why AAA management crosses several clinical settings. Primary care and preventive services identify people for screening, vascular laboratories standardise measurement, vascular clinics run surveillance and risk modification, and the aortic team decides when open or endovascular repair is justified. Contemporary society documents from the United States, Europe, and Korea share this general sequence while differing in some eligibility, interval, sex-specific, and post-EVAR details KVSS 2026 · Editor's Choice European 2024 · USPSTF 2019 · SVS 2018.

18.2AAA biology and natural history in one paragraph

The definition is straightforward: an abdominal aortic aneurysm is an infrarenal aortic diameter of 3.0 cm or greater when measured consistently by ultrasound or cross-sectional imaging Reporting standards endovascular 2002. The biology behind that number involves more than passive dilatation. AAA reflects a chronic degenerative process in the aortic wall, influenced by age, smoking exposure, sex, family history, systemic atherosclerotic risk, and local wall remodelling. Most small aneurysms are clinically silent; surveillance aims to prevent future events rather than treat current symptoms.

Diameter remains the main management language because it is reproducible, teachable, and linked to rupture risk, but it is an imperfect summary of wall strength. Growth rate, saccular morphology, symptoms, patient size, sex, and operative fitness all modify the meaning of the same diameter. Detection is therefore not a one-off diagnosis; it commits the patient to longitudinal measurement, cardiovascular risk reduction, and repeated assessment of the point at which repair risk becomes preferable to rupture risk Editor's Choice European 2024 · USPSTF 2019.

18.3Screening: who benefits from a one-time ultrasound?

AAA screening begins with patient selection. In an asymptomatic adult, the question is whether the patient belongs to a group in which one-time ultrasound detects enough clinically important aneurysm to justify the program, the downstream surveillance burden, and possible elective repair. The strongest and most durable screening signal is in older men with smoking exposure. The 2019 USPSTF statement gives a Grade B recommendation for one-time ultrasound in men aged 65–75 years who have ever smoked, defines ever smoking as at least 100 lifetime cigarettes, supports selective screening in men aged 65–75 years who never smoked, finds insufficient evidence for women aged 65–75 years with smoking exposure or family history, and recommends against routine screening in women without those risk factors USPSTF 2019.

The SVS 2018 guideline takes a vascular-practice view and recommends one-time abdominal duplex ultrasound for men or women aged 65–75 years with a tobacco history SVS 2018. ESVS 2024 and KVSS 2026 place screening inside broader regional aneurysm pathways, with the same need to separate population screening from individualised testing in a high-risk patient KVSS 2026 · Editor's Choice European 2024. Documenting the eligibility reason at the time of ordering is good practice; doing so avoids later confusion when a borderline or small aneurysm creates years of follow-up.

18.4How major guidelines line up on AAA management

The major guidelines agree on the architecture of care: detect clinically important AAA with ultrasound, measure consistently, follow small aneurysms in diameter bands, consider repair when size or behavior crosses the elective threshold, and continue surveillance after EVAR to prevent late failure KVSS 2026 · Editor's Choice European 2024 · SVS 2018. USPSTF guidance is narrower because it addresses preventive screening rather than the full operative pathway, but it supplies the population-screening frame that many primary-care systems use USPSTF 2019.

The differences matter clinically because they often sit in the cells clinicians quote from memory: who qualifies for screening, how to handle women and family history, whether a subaneurysmal aorta needs delayed re-imaging, the interval for each surveillance band, how much rapid growth should trigger re-measurement or repair assessment, and how intensive post-EVAR imaging should be. A patient should be managed against the current local guideline and local imaging program, while the cross-society comparison helps the clinician recognise where a number is broadly shared and where it is region-specific.

18.5Trial evidence that anchors screening and small-AAA decisions

The reason one-time screening persists in modern guidance is that the randomized population trials showed a signal that mattered clinically, especially in men. MASS randomized 67,800 United Kingdom men to invitation for one-time ultrasound screening or usual care; the original report found a 42% relative reduction in AAA-related mortality at about four years, and later follow-up showed persistence of benefit at ten and thirteen years Final follow-up Multicentre 2012 · Screening men abdominal 2009 · Multicentre Aneurysm Screening 2002. Pooled evidence syntheses reached the same direction of effect in men: the 2007 Cochrane analysis reported an AAA-mortality odds ratio of 0.60 in men aged 65–79 years, while the USPSTF evidence synthesis reported a long-term AAA-mortality odds ratio of 0.65 in men aged 65 years or older Primary Care Screening 2019 · Screening abdominal aortic 2007. The same pooled evidence has not made the women-screening question clean, because the available trial estimate in women was imprecise rather than reassuring.

VIVA is important because it tested screening as a vascular-prevention intervention rather than as an AAA-only intervention. In 50,156 Danish men aged 65–74 years, invitation to combined AAA, peripheral artery disease, and hypertension screening was associated with lower all-cause mortality, but the bundled design means the AAA-specific component cannot be isolated cleanly Population screening intervention 2017. UKSAT answers the question that follows detection: should a small aneurysm be repaired early? In 1,090 adults with 4.0–5.5 cm aneurysms, early open repair did not improve all-cause survival compared with surveillance, with a reported hazard ratio of 0.94 and a 5.8% thirty-day operative mortality in the early-repair arm Immediate repair compared 2002. That finding is the clinical root of modern small-AAA surveillance: most small aneurysms deserve scheduled observation until their size, growth, morphology, symptoms, or patient context changes the balance.

18.6Small-AAA surveillance: the imaging schedule that follows detection

A detected small AAA should not drift between unscheduled scans. Surveillance is a safety system: the next imaging date is determined by the current diameter, the measurement method should be consistent, and any apparent jump in size should be checked before it is treated as true biological growth. Ultrasound is usually the surveillance modality because it is non-invasive and well suited to serial diameter measurement; CT or MR angiography becomes more important when ultrasound windows are poor, anatomy is being mapped for repair, or symptoms raise concern for another process Editor's Choice European 2024 · SVS 2018.

SVS 2018 gives a clear example of banded follow-up: ultrasound every 36 months for 3.0–3.9 cm AAA, every 12 months for 4.0–4.9 cm AAA, and every 6 months for 5.0–5.4 cm AAA SVS 2018. It also recommends repeat ultrasound at 10 years for an initial aortic diameter of 2.5–3.0 cm, reflecting the clinical distinction between a normal aorta and a subaneurysmal one. The NHS AAA Screening Program illustrates the operational version of the same principle: small aneurysms are usually followed annually, medium aneurysms more frequently, and large aneurysms are referred for vascular assessment Quality assurance NHS 2022.

Growth rate should be interpreted with the same discipline as diameter. A 2024 evidence synthesis reported pooled AAA growth around 2.38 mm per year overall, with lower estimates in RCT-only and low-risk-of-bias cohorts, so a much larger apparent interval change should prompt concern about either true acceleration or measurement variation Editor's Choice Systematic 2024. ESVS 2024 treats growth of at least 10 mm per year as a signal to re-measure with the same imaging modality before triggering the repair pathway, which is a useful safeguard against operating on measurement noise Editor's Choice European 2024.

18.7When does an asymptomatic AAA become a candidate for repair?

Elective repair is justified when the expected rupture risk during continued surveillance exceeds the combined risk and burden of intervention, and that judgment begins with diameter but should not end there. For asymptomatic fusiform infrarenal AAA in men, SVS 2018 recommends repair at 5.5 cm or larger, ESVS 2024 supports elective repair at 55 mm or larger while recommending against repair below 55 mm, and KVSS 2026 uses a 50–55 mm men's threshold band in its regional guidance KVSS 2026 · Editor's Choice European 2024 · SVS 2018. For women, SVS 2018 supports considering repair at 5.0–5.4 cm, whereas ESVS 2024 explicitly recommends against repair below 50 mm; the absence of a single shared women-specific cell is one reason sex-specific counseling should be explicit rather than hidden in a generic threshold.

Saccular morphology is the classic example of why diameter-only thinking fails. SVS 2018, ESVS 2024, and KVSS 2026 all treat saccular AAA as a morphology that can justify earlier repair consideration than a fusiform aneurysm of the same maximum diameter, but none of these guidance statements converts that concept into a universal numeric offset KVSS 2026 · Editor's Choice European 2024 · SVS 2018. Rapid growth, tenderness, pain, embolic symptoms, and impending rupture signs similarly move the patient out of routine surveillance and into urgent vascular assessment. The repair conversation should then become anatomical and patient-specific: open repair and EVAR have different risk profiles, durability profiles, and surveillance obligations.

18.8Medical therapy: what we can and cannot promise the patient

The medical consultation for AAA has two separate aims. The first is cardiovascular prevention: the patient with AAA is usually a patient with systemic vascular risk, so smoking cessation, blood-pressure treatment, lipid management, antiplatelet decisions when otherwise indicated, diabetes care, exercise advice, and perioperative optimization matter even if the aneurysm diameter never changes Editor's Choice European 2024 · SVS 2018. The second aim is aneurysm-specific growth modification, and here the evidence is much less ready for promises.

Statins are appropriate for cardiovascular risk reduction in most patients with AAA when standard vascular-prevention indications are present. A 2018 meta-analysis reported associations between statin use and lower AAA growth, rupture, and perioperative mortality, including a mean growth-rate difference of about 0.82 mm per year, but the growth analysis was heterogeneous and not the same as an AAA-specific randomized treatment effect Statins Reduce Abdominal 2018. The patient-facing message should therefore be precise: use the statin for vascular risk, not as a guaranteed aneurysm-slowing drug.

Medication safety is also part of aneurysm care. Fluoroquinolone exposure has been associated with short-term aortic aneurysm or dissection events in systematic analyses of observational and pharmacovigilance data, so an alternative antibiotic is generally preferable when it is clinically reasonable in a patient with known AAA or other aortic disease Fluoroquinolones 2026. Metformin and diabetes-related biology create a different kind of signal: observational syntheses report an inverse association between metformin exposure and AAA growth or clinical events, but no AAA-specific randomized trial supports starting metformin solely for aneurysm control Editor's Choice Association 2021 · Bell 2026.

18.9Sex, family history, and other modifiers of the AAA pathway

The same aneurysm diameter does not always mean the same clinical risk. Women with AAA tend to enter the pathway differently from men, and contemporary outcome synthesis after EVAR reports worse short-term outcomes in women, including higher 30-day and in-hospital mortality odds in pooled analyses EVAR 2026. While this does not mean every woman should be screened or repaired earlier, screening eligibility, repair threshold, body size, anatomy, and operative risk should be discussed as sex-specific variables. The USPSTF, SVS, and ESVS positions on women differ enough that the local recommendation should be named during counseling Editor's Choice European 2024 · USPSTF 2019 · SVS 2018.

Family history changes the pre-test probability and should be asked about directly, especially in first-degree relatives of patients with AAA. Ethnicity and regional prevalence also influence policy: a systematic synthesis of Asian populations reported pooled AAA prevalence of 1.30% overall and 2.56% in cardiovascular-risk subgroups, which is one reason Asian-region guidance deserves attention rather than simple importation of Western prevalence assumptions KVSS 2026 · Systematic review meta-analysis 2021.

18.10Post-EVAR follow-up: imaging the repaired aorta

EVAR converts the aneurysm problem into a lifelong seal, sac, and device problem. Surveillance must confirm whether the sac remains excluded without endoleak, migration, limb compromise, loss of seal, or continued expansion. SVS 2018 and ESVS 2024 both support structured post-EVAR imaging, although the modality mix and intensity are increasingly tailored to early findings and local program performance Editor's Choice European 2024 · SVS 2018.

CTA remains valuable because it shows seal zones, sac geometry, branch vessels, device position, and complications in one study. Duplex ultrasound and contrast-enhanced duplex can reduce contrast and radiation exposure in selected stable patients, but they require experienced laboratories and clear escalation rules. In pooled diagnostic data, contrast-enhanced color duplex ultrasound had sensitivity 0.94 and specificity 0.95 for endoleak detection after EVAR, compared with sensitivity 0.82 and specificity 0.93 for non-contrast color duplex Ultrasonography endoleak detection 2017. Sac behavior should be taken seriously even when the imaging label is uncertain; diameter is practical, but volume-based assessment may identify change that diameter alone can miss Abdominal Aortic Aneurysm 2023. Late rupture after EVAR is uncommon, with a systematic synthesis reporting cumulative incidence around 0.9%, but it is catastrophic enough that surveillance is not optional when a patient remains fit for rescue intervention Late Rupture Abdominal 2015.

18.11Putting it together: the AAA decision pathway

The AAA pathway can be run as four linked decisions. First, decide whether the person qualifies for one-time ultrasound screening under the local screening recommendation Editor's Choice European 2024 · USPSTF 2019 · SVS 2018. Second, interpret the ultrasound by a consistent diameter standard: below the aneurysm threshold generally exits the AAA pathway or enters delayed re-imaging if subaneurysmal, while 3.0 cm or greater establishes AAA and assigns the patient to surveillance or repair assessment according to size and context Reporting standards endovascular 2002.

Third, run surveillance as an active loop: use the right interval, compare like with like, re-measure unexpected jumps, and escalate symptoms, rapid growth, or saccular morphology Editor's Choice European 2024 · SVS 2018. Fourth, when repair is chosen, decide open repair or EVAR from anatomy, physiology, durability, and patient preference, and write the post-repair imaging plan before the patient leaves the repair pathway.

18.12Where the guidance is still moving

The unsettled parts of AAA care are clinically important because they change what a patient hears in clinic. Screening women remains the most visible example: the trial base is weaker, the prevalence is lower, rupture and outcome patterns differ from men, and society recommendations do not reduce to a single rule Editor's Choice European 2024 · USPSTF 2019 · SVS 2018 · EVAR 2026. A first-degree family history, Asian-region prevalence data, and local service capacity may shift the discussion, but they do not remove the need to explain uncertainty honestly KVSS 2026 · Systematic review meta-analysis 2021.

Thresholds are also still being refined. Saccular morphology is widely treated as higher concern, yet it has no universal diameter subtraction rule; rapid growth is a trigger for re-measurement and repair assessment, but the exact action depends on the guideline and clinical context KVSS 2026 · Editor's Choice European 2024 · SVS 2018. Drug treatment remains another moving area: statin and metformin signals are biologically and observationally interesting, while fluoroquinolone caution is practical, but none of these turns a surveillance patient into a medical-cure patient Fluoroquinolones 2026 · Statins Reduce Abdominal 2018 · Bell 2026.